Dana Pizzuti is Chief Med and Dev Officer at Crinetics Pharmaceuticals, Inc. (CRNX). They have made 3 open-market trades across 1 company since 2023, most recently 2025-12-01.
CIK 0001948238
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CRNX | 66,837 | $5.7M |
Shares reported on the most recent Form 4, priced at the 2025-12-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRNX | SELL · 10b5-1 | 2025-12-01 | 2025-12-03 | $45.02 | $450K | +5.3% | -0.2% | -14.3% |
| CRNX | SELL · 10b5-1 | 2025-11-03 | 2025-11-05 | $42.66 | $213K | +1.9% | +9.2% | +16.9% |
| CRNX | SELL · 10b5-1 | 2025-10-01 | 2025-10-03 | $41.81 | $209K | +7.6% | +4.4% | +13.9% |
| CRNX | SELL · 10b5-1 | 2025-09-02 | 2025-09-04 | $32.10 | $161K | -0.8% | +21.2% | +36.6% |
| CRNX | SELL · 10b5-1 | 2025-08-22 | 2025-08-26 | $30.43 | $913K | +13.7% | +16.1% | +41.9% |
| CRNX | SELL · 10b5-1 | 2025-08-20 | 2025-08-21 | $29.18 | $379K | +16.3% | +13.2% | +44.0% |
| CRNX | SELL · 10b5-1 | 2025-03-19 | 2025-03-21 | $34.19 | $168K | -9.3% | -12.9% | -12.9% |
| CRNX | SELL · 10b5-1 | 2025-02-03 | 2025-02-05 | $39.07 | $195K | -9.3% | -15.0% | -22.1% |
| CRNX | SELL · 10b5-1 | 2025-01-03 | 2025-01-07 | $52.09 | $781K | -21.3% | -21.4% | -46.4% |
| CRNX | SELL · 10b5-1 | 2024-10-03 | 2024-10-07 | $54.63 | $1.6M | +13.3% | +13.8% | -2.9% |
| CRNX | SELL · 10b5-1 | 2024-07-03 | 2024-07-05 | $44.87 | $1.3M | +21.6% | +11.0% | +19.1% |
| CRNX | SELL | 2024-06-24 | 2024-06-25 | $45.73 | $869K | +2.2% | +20.2% | +13.6% |
| CRNX | SELL · 10b5-1 | 2024-04-15 | 2024-04-17 | $44.47 | $1.3M | -0.1% | +16.7% | +24.8% |
| CRNX | SELL | 2024-03-20 | 2024-03-22 | $44.47 | $866K | +6.9% | -0.4% | +1.4% |
| CRNX | SELL · 10b5-1 | 2024-01-03 | 2024-01-04 | $35.00 | $503K | +7.8% | +10.3% | +39.5% |
| CRNX | SELL | 2023-12-21 | 2023-12-22 | $34.57 | $663K | -3.3% | +1.9% | +25.1% |
| CRNX | SELL · 10b5-1 | 2023-04-05 | 2023-04-05 | $16.15 | $265K | +5.8% | +40.3% | +13.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.